---
document_datetime: 2023-09-21 18:31:31
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/pedea-epar-all-authorised-presentations_en.pdf
document_name: pedea-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6527321
conversion_datetime: 2025-12-28 19:35:27.447951
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical form    | Route of administration   | Packaging            | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|------------------------|---------------------------|----------------------|---------------------------|----------------|
| EU/1/04/284/001 | Pedea           | 5 mg/ml    | Solution for injection | Intravenous use           | Ampoule (glass) 2 ml |                           | 4 ampoules     |